Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3856 AL 3870

Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia

Liu-Seifert H, Siemers E, Sundell K, Price K, Han B, Selzler K, Aisen P, Cummings J, Raskin J, Mohs R.

J Alzheimers Dis. 2015;43(3):949-55. doi: 10.3233/JAD-140792.

Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study

Sousa MF, Santos RL, Nogueira ML, Belfort T, Rosa RD, Torres B, Simões P, Mograbi DC, Laks J, Dourado MC.

J Alzheimers Dis. 2015;43(3):905-13. doi: 10.3233/JAD-140342.

Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia

Spehl TS, Frings L, Hellwig S, Weiller C, Hüll M, Meyer PT, Amtage F.

Clin Nucl Med. 2015 Jan;40(1):e27-33. doi: 10.1097/RLU.0000000000000554.

Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis

Zhu XC, Yu Y, Wang HF, Jiang T, Cao L, Wang C, Wang J, Tan CC, Meng XF, Tan L, Yu JT.

J Alzheimers Dis. 2015;44(1):163-74. doi: 10.3233/JAD-141377.

Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study

Olde Rikkert MG, Verhey FR, Blesa R, von Arnim CA, Bongers A, Harrison J, Sijben J, Scarpini E, Vandewoude MF, Vellas B, Witkamp R, Kamphuis PJ, Scheltens P.

J Alzheimers Dis. 2015;44(2):471-80. doi: 10.3233/JAD-141305.

Trazodone and cognitive performance in Alzheimer disease

Camargos EF, Quintas JL, Louzada LL, Naves JO, Furioso AC, Nóbrega OT.

J Clin Psychopharmacol. 2015 Feb;35(1):88-9. doi: 10.1097/JCP.0000000000000237.

Downsizing of lean body mass is a key determinant of Alzheimer's disease

Ingenbleek Y, Bernstein LH.

J Alzheimers Dis. 2015;44(3):745-54. doi: 10.3233/JAD-141950.

The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial

Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S.

J Alzheimers Dis. 2015;44(4):1157-69. doi: 10.3233/JAD-142265.

Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor

Grossberg GT, Farlow MR, Meng X, Velting DM.

Curr Alzheimer Res. 2015;12(1):53-60. doi: 10.2174/1567205011666141218122835.

New horizons in the management of Alzheimer disease

Morley JE.

J Am Med Dir Assoc. 2015 Jan;16(1):1-5. doi: 10.1016/j.jamda.2014.10.022.

Cognitive-motor intervention in Alzheimer's disease: long-term results from the Maria Wolff trial

Muñiz R, Serra CM, Reisberg B, Rojo JM, Del Ser T, Peña Casanova J, Olazarán J.

J Alzheimers Dis. 2015;45(1):295-304. doi: 10.3233/JAD-142364.

18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease

Bailly M, Ribeiro MJ, Vercouillie J, Hommet C, Gissot V, Camus V, Guilloteau D.

Clin Nucl Med. 2015 Feb;40(2):e111-6. doi: 10.1097/RLU.0000000000000666.

Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease

Wischik CM, Staff RT, Wischik DJ, Bentham P, Murray AD, Storey JM, Kook KA, Harrington CR.

J Alzheimers Dis. 2015;44(2):705-20. doi: 10.3233/JAD-142874.

Cerebrospinal fluid total prion protein: a potential in vivo marker of cerebral prion pathology

Zetterberg H.

JAMA Neurol. 2015 Mar;72(3):261-3. doi: 10.1001/jamaneurol.2014.4078.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias